ESMO Faculty| Latest update 13 February 2019 1

_____________________________________________________________________________________________________

ESMO Faculty _____________________________________________________________________________________________________

ESMO Faculty| Latest update 13 February 2019 2

FACULTY STRUCTURE 3

HEAD AND NECK CANCER 4

LUNG AND OTHER THORACIC TUMOURS 5

GASTRO-INTESTINAL TUMOURS 7

BREAST CANCER 9

GYNECOLOGIC CANCER 13

GENITOURINARY CANCER 14

SARCOMA 16

HEMATOLOGIC MALIGNANCY 18

PRINCIPLES OF CLINICAL TRIALS AND SYSTEMIC THERAPY 19

CANCER RESEARCH 21

CANCER PREVENTION 22

SUPPORTIVE AND PALLIATIVE CARE 23

CANCER GENETICS 25

CNS TUMOURS 26

NEUROENDOCRINE, ENDOCRINE NEOPLASMS AND CUP 27

MELANOMA 29

TUMOUR IMMUNOLOGY AND IMMUNOTHERAPY 30

ESMO Faculty| Latest update 13 February 2019 3

Faculty structure

ESMO Faculty Group Coordinator Term of Office 1 Head and Neck Cancer J-P. Machiels, BE 2017-2020

2 Lung and Other Thoracic Tumours R. Dziadziuszko, PL 2019-2020

3 Gastro-Intestinal Tumours F. Lordick, DE 2017-2020

4 Breast Cancer G. Curigliano, IT 2019-2020

5 Gynecologic Cancer A. González Martín, ES 2017-2020

6 Genitourinary Cancer A. Bamias, GR 2017-2020

7 Sarcoma J. Martin Broto, ES 2017-2020

8 Hematologic Malignancy C. Buske, DE 2017-2020

9 Principles of Clinical Trials and Systemic Therapy A. Awada, BE 2017-2020

10 Cancer Research C. Caldas, UK 2019-2020

11 Cancer Prevention N. Arber, IL 2019-2020

12 Supportive and Palliative Care K. Jordan, DE 2017-2020

13 Cancer Genetics J. Balmaña, ES 2017-2020

14 CNS Tumours E. Le Rhun, FR 2017-2020

15 Neuroendocrine, Endocrine Neoplasms and CUP N. Fazio, IT 2016-2019

16 Melanoma O. Michielin, CH 2017-2020

17 Tumour Immunology and Immunotherapy J. Haanen, NL 2016-2019

ESMO Faculty| Latest update 13 February 2019 4

Head and Neck Cancer

Name Country/Institute/City Term of Office Faculty Coordinator: Jean-Pascal Machiels Belgium, Cliniques Universitaires St. Luc, Brussels 2017-2020 Diogo Alpium Costa Portugal, CUF Cancer Center, Lisbon 2017-2021 Paolo Bossi Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Jean Bourhis France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Irene Braña Garcia Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Ana Castro Portugal, Centro Hospitalar do Porto, Porto 2017-2021 Anthony Chan Hong Kong, The Chinese University of Hong Kong, Shatin 2017-2021 Andreas Dietz Germany, University of Leipzig, Leipzig 2017-2021 Isabel Fonseca Portugal, Instituto de Anatomia Patologica, Lisbon 2017-2021 Viktor Grünwald Germany, University Hospital Essen Westdeutsches Tumorzentrum, Essen 2017-2021 Joel Guigay France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021

Kevin Harrington UK, The Institute of Cancer Research, London 2017-2021 Bhumsuk Keam Korea, Seoul National University Hospital, Seoul 2019-2023 Johannes A. Langendijk Netherlands, University Medical Centre Groningen, Groningen 2017-2021 C. René Leemans Netherlands, VU University Medical Center, Amsterdam 2017-2021 Jean-Louis Lefebvre France, Centre Oscar Lambret, Lille 2017-2021 Lisa Licitra Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Marco Merlano Italy, Azienda Ospedaliera St. Croce e Carle, Cuneo 2017-2021 Ricardo Mesia Nin Spain, Catalan Institute of Oncology, Barcelona 2017-2021 Piero Nicolai Italy, Department of Otolaryngology-Head and Neck Surgery, University of Brescia, Brescia 2017-2021 Sjoukje Oosting Netherlands, University Medical Center Groningen, Groningen 2017-2021 Amanda Psyrri Greece, Attikon University Hospital, Athens 2017-2021 Sandra Schmitz Belgium, Saint-Luc University Hospital, Brussels 2017-2021 Christian Simon Switzerland, CHUV, UNIL, Lausanne 2017-2021 Makoto Tahara Japan, National Cancer Center Hospital East, Chiba 2017-2021 Carla Van Herpen Netherlands, Radboud University Medical Center Nijmegen, Nijmegen 2017-2021 Jan B. Vermorken Belgium, U.Z.A. University Hospital Antwerp, Edegem 2017-2021

ESMO Faculty| Latest update 13 February 2019 5

Lung and other Thoracic Tumours

Name Country/Institute/City Term of Office Faculty Coordinator: Rafal Dziadziuszko Poland, Medical University of Gdansk, Gdansk 2019-2020 Paul Baas Netherlands, The Netherlands Cancer Institute (NKI), Amsterdam 2017-2021 Fabrice Barlesi France, North Hospital, Multidisciplinary Oncology & Therapeutic Innovation, Marseille 2017-2021 Benjamin Besse France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021

Lukas Bubendorf Switzerland, University Hospital Basel, Basel 2017-2021 Antonio Calles Spain, Hospital General Universitario Gregorio Marañon, Madrid 2019-2023 Federico Cappuzzo Italy, Ospedale Civile, Istituto Toscano Tumori, Livorno 2017-2021 Fortunato Ciardiello Italy, Università della Campania L. Vanvitelli, Naples 2017-2021 Lucio Crinò Italy, Ospedale S. Maria della Misericordia, S. Andrea della Fratte 2017-2021 Tanja Cufer Slovenia, University Clinic Golnik, Golnik 2017-2021 Filippo de Marinis Italy, Azienda Ospedaliera S. Camillo Forlanini, Rome 2017-2021 Dirk de Ruysscher Netherlands, Maastricht University Medical Center (MUMC), Maastricht 2017-2021 Anne-Marie Dingemans Netherlands, Maastricht University Medical Center (MUMC), Maastricht 2017-2021 Rafal Dziadziuszko Poland, Medical University of Gdansk, Gdansk 2017-2021 Wilfried Eberhardt Germany, University Hospital Essen, Essen 2017-2021 Martin Edelman USA, University of Maryland, Baltimore 2017-2021 Simon Ekman Sweden, Uppsala University, Uppsala 2017-2021 Enriqueta Felip Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021

Pier Luigi Filosso Italy, Azienda Ospedaliero Universitaria San Giovanni Battista di Torino, Torino 2018-2022 Rabab M. Gaafar Egypt, NCI Cairo University, Cairo 2017-2021 Marina Garassino Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Pilar Garrido Lopez Spain, Hospital Ramon y Cajal, Madrid 2017-2021 Oliver Gautschi Switzerland, Insel Spital, Bern 2017-2021 Ramaswamy Govindan USA, Washington University School of Medicine, St. Louis 2017-2021 Vanesa Gregorc Italy, San Raffaele Insitute, Milan 2017-2021 Cesare Gridelli Italy, Azienda Ospedaliera S. Giuseppe Moscati, Avellino 2017-2021 Dominique Grunenwald France, Tenon University Hospital, Paris 2017-2021 Pasi Jänne USA, Dana Farber Cancer Institute, Boston 2017-2021 Keith Kerr UK, Aberdeen Royal Infirmary, Aberdeen 2017-2021 Paris A. Kosmidis Greece, Hygeia Hospital, Athens 2017-2021 Cécile Le Pechoux France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021

Tetsuya Mitsudomi Japan, Aichi Cancer Center, Nagoya 2017-2021

ESMO Faculty| Latest update 13 February 2019 6

Tony S.K. Mok China, Chinese University of Hong Kong, Hong Kong 2017-2021 Floriana Morgillo Italy, University of Campania Luigi Vanvitelli, Naples 2017-2021 Giannis Mountzios Greece, University of Athens School of Medicine Clinical Therapeutics, Athens 2019-2023 Kenneth O’Byrne Ireland, St. James’s Hospital, Dublin 2017-2021 Antonio Passaro Italy, Istituto Europeo di Oncologia, Milan 2019-2023 Luis Paz-Ares Spain, University Hospital 12 De Octubre, Madrid 2017-2021 Solange Peters Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Robert Pirker Austria, Medical University of Vienna, Wien 2017-2021 Sanjay Popat UK, Royal Marsden Hospital NHS Foundation Trust, London 2017-2021 Pieter E. Postmus Netherlands, VU University Medical Center, Amsterdam 2017-2021 Martin Reck Germany, Lung Clinic Grosshansdorf, Grosshansdorf 2019-2023 Noemi Reguart Spain, Hospital Clinic de Barcelona, Barcelona 2017-2021

Niels Reinmuth Germany, Lung Clinic Grosshansdorf, Grosshansdorf 2017-2021

Rafael Rosell Spain, Catalan Institute of Oncology, Badalona 2017-2021 Suresh Senan Netherlands, VU University Medical Center, Amsterdam 2017-2021 Egbert F. Smit Netherlands, VU University Medical Center, Amsterdam 2017-2021 Lorenzo Spaggiari Italy, European Institute of Oncology, Milan 2018-2022 James Spicer UK, King's College London Guy's Hospital, London 2017-2021 Rolf A. Stahel Switzerland, University Hospital Zurich, Zurich 2017-2021 Kostantinos Syrigos Greece, Sotiria General Hospital, Athens 2017-2021 Wan Ling Tan Singapore, NCCS - National Cancer Centre Singapore 2019-2023 Johan Vansteenkiste Belgium, University Hospital Gasthuisburg, Leuven 2017-2021 Walter Weder Switzerland, University Hospital Zurich, Zurich 2017-2021

ESMO Faculty| Latest update 13 February 2019 7

Gastro-Intestinal Tumours

Name Country/Institute/City Term of Office Faculty Coordinator: Florian Lordick Germany, University of Leipzig, Leipzig 2017-2020 René Adam France, University Hospital Paul Brousse, Villejuif 2017-2021 Antoine Adenis France, Institut de Cancérologie de Montpellier, Montpellier 2017-2021 Salah-Eddin Al-Batran Germany, Krankenhaus Nordwest, Frankfurt am Main 2017-2021 William Allum UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Cheng Ann-Lii Taiwan, National Taiwan University Hospital, Taipei 2018-2022 Guillem Argilés Spain, Vall d'Hebron University Hospital, Barcelona 2019-2023 Dirk Arnold Germany, University Medical Center Hamburg-Eppendorf, Hamburg 2017-2021

Jorge Barriuso UK, The Christie NHS Foundation Trust, Manchester 2019-2023 Regina Beets Tan Netherlands, Maastricht University Medical Center, Maastricht 2017-2021 Irit Ben-Aharon Israel, Rambam Health Care Centre, Haifa 2018-2022 Yung-Jue Bang Republic of Korea, Seoul National University Hospital, Seoul 2018-2022 Frederic Bibeau France, Centre Hospitalier Universitaire de Caen, Caen 2017-2021 Gyoergy Bodoky Hungary, St. László Hospital, Dept. of Oncology, Budapest 2017-2021 Gina Brown UK, The Royal Marsden NHS Foundation Trust and Imperial College London, London 2017-2021 Fátima Carneiro Belgium, The European Society of Pathology, Brussels 2017-2021 Alfredo Carrato Spain, Ramon y Cajal Institute for Health Research, Madrid 2017-2021 Stefano Cascinu Italy, AOU Ospedali Riuniti Ancona, Ancona 2017-2021 Andrés Cervantes Ruiperez Spain, University Hospital of Valencia, Valencia 2017-2021 Chung Yip Chan Singapore General Hospital, Singapore 2017-2021 Ian Chau UK, The Royal Marsden Hospital, Sutton 2017-2021 Min Hoe Chew Singapore, Sengkang Hospital, Singapore 2017-2021 Dawn Qingqing Chong Singapore, National Cancer Centre Singapore 2017-2021 Su Pin Choo Singapore, National Cancer Center, Singapore 2017-2021 Clarinda Wei Ling Chua Singapore, National Cancer Center, Singapore 2017-2021 Fortunato Ciardiello Italy, Università della Campania L. Vanvitelli, Naples 2017-2021 Thierry Conroy France, Centre Alexis Vautrin, Vandoeuvre Les Nancy 2017-2021 Chiara Cremolini Italy, Azienda Ospedaliero Universitaria Pisana, Pisa 2017-2021 Thierry de Baere France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Ramon Andrade De Mello Portugal, University of the Algarve-Biomedical Sciences and Medicine, Faro 2018-2022 Eduardo Diaz Rubio Spain, University Hospital San Carlos, Madrid 2017-2021 Jean-Yves Douillard Switzerland, European Society for Medical Oncology, Lugano 2017-2021

ESMO Faculty| Latest update 13 February 2019 8

Michel Ducreux France, Institut Gustave Roussy, Villejuif 2017-2021 Elena Elez Fernandez Spain, Vall d`Hebron Institute of Oncology (VHIO), Barcelona 2018-2022 Alfredo Falcone Italy, Azienda Ospedaliero Universitaria Pisana, Pisa 2017-2021 Nicola Fazio Italy, European Institute of Oncology, Milan 2017-2021 Jorge Gallardo Mexico, Hospital Regional Ignacio Zaragoza ISSSTE, Ciudad de Mexico 2018-2022 Robert Glynne-Jones UK, Mount Vernon Cancer Center, Northwood 2017-2021 Ullrich Graeven Germany, Kliniken Maria Hilf GmbH, Mönchengladbach 2017-2021 Ulrich Güller Switzerland, Cantonal Hospital St. Gallen, St. Gallen 2017-2021 Chiun Hsu Taiwan, National Taiwan University Hospital, Taipei 2017-2021 Konstantinos Kamposioras UK, The Mid Yorkshire Hospitals NHS Trust-Pinderfields General Hospital, Wakefield 2018-2022 Yoon-Koo Kang South Korea, University of Ulsan College of Medicine, Seoul 2018-2022 Michalis Karamouzis Greece, National and Kapodistrian University of Athens, Athens 2017-2021 Volker Heinemann Germany, Ludwig Maximilians University, Munich 2017-2021 Claus-Henning Koehne Germany, Städtisches Klinikum Oldenburg, Oldenburg 2017-2021 Miriam Koopman Netherlands, University Hospital Utrecht, Utrecht 2017-2021 Stefan Kubicka Germany, Kreisklinlken Reutlingen GmbH, Reutlingen 2017-2021 Roberto Labianca Italy, Ospedali Riuniti di Bergamo, Bergamo 2017-2021

Cord Langner Austria, Institute of Pathology, Medical University of Graz, Graz 2017-2021 Tony Kiat Hon Lim Singapore General Hospital, Singapore 2017-2021 Fotios Loupakis Italy, Azienda Ospedaliero Universitaria Pisana, Pisa 2017-2021

Brigette Buig Yue Ma Hong Kong, The Chinese University of Hong Kong, Shatin 2017-2021 Teresa Macarulla Spain, Vall d`Hebron Institute of Oncology (VHIO), Barcelona 2018-2022 Erika Martinelli Italy, Second University of Naples, Naples 2017-2021 Kei Muro Japan, Aichi Cancer Center Hospital, Nagoya 2017-2021 Magnus Nilsson Sweden, Karolinska University Hospital, Stockholm 2019-2023 Juan Manuel O’Connor Argentina, Alexander Fleming Institute, Buenos Aires 2018-2022 Radka Obermannová Czech Republic, Masaryk University - Comprehensive Cancer Care Department, Brno 2017-2021 Joao Oliveira Portugal, Portuguese Institute of Oncology of Lisbon, Lisbon 2017-2021 Pia Johanna Österlund Finland, Tampere University Hospital, Tampere 2017-2021 Demetris Papamichael Cyprus, Bank of Cyprus Oncology Centre, Strovolos 2017-2021 Russell Petty UK, University of Dundee, Dundee 2017-2021 Per Pfeiffer Denmark, Odense University Hospital, Odense C. 2017-2021 Gerald Prager Austria, Comprehensive Cancer Center, Vienna 2017-2021 Cornelis J.A. Punt Netherlands, Academic Medical Center, University of Amsterdam, Amsterdam 2017-2021 Ana Cristina Raimundo Portugal, Instituto Portugues de Oncologia do Porto (IPO-Porto), Lisbon 2017-2021 Sheela Rao UK, Royal Marsden Hospital NHS Foundation Trust, London 2019-2023 Jean-Luc Raoul France, ICO - Institute of Cancer Research in Western France, Nantes 2017-2021 Sun Young Rha Republic of Korea, Yonsei University, Seoul 2017-2021

ESMO Faculty| Latest update 13 February 2019 9

Fernando Rivera Herrero Spain, Hospital Universitario Marqués de Valdecilla, Santander 2017-2021 Arnaud D. Roth Switzerland, University Hospital Geneva, Geneva 2017-2021 Erika Ruíz-García Mexico, Instituto Nacional de Cancerologia, Ciudad de Mexico 2018-2022 Ramon Salazar Spain, Institut Català d'Oncologia Hospital Duran i Reynals, Barcelona 2017-2021 Mark Saunders UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Werner Scheithauer Austria, Medical University of Vienna, Vienna 2017-2021 Francesco Sclafani UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Eva Segelov Australia, Monash Medical Centre, Clayton 2018-2022 Thomas Seufferlein Germany, University Hospital Ulm, Ulm 2017-2021 Matt Seymour UK, The Leeds Teaching Hospital NHS, Leeds 2017-2021

Salvatore Siena Italy, Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan 2017-2021 Elizabeth Smyth UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Jimmy Bok-Yan So Singapore, National University Cancer Institute, Singapore 2017-2021 Alberto Sobrero Italy, National Institute for Cancer Research, Genoa 2017-2021 Halfdan Sorbye Norway, Haukeland University Hospital, Bergen 2017-2021 Michael Stahl Germany, Kliniken Essen Mitte, Essen 2017-2021 Alexander Stein Germany, University Medical Center Hamburg-Eppendorf, Hamburg 2017-2021 Sebastian Stintzing Germany, Ludwig Maximilians University of Munich, Munich 2017-2021 Sho Suzuki Japan, Nihon University School of Medicine, Tokyo 2017-2021 Josep Tabernero Spain, Vall d’Hebron University Hospital, Barcelona 2017-2021 Julien Taieb France, Hôpital Européen Georges-Pompidou, Paris 2017-2021 Patrick Tan Singapore, Duke-NUS Graduate Medical School, Singapore 2017-2021 Bee Huat Iain Tan Singapore, National Cancer Centre Singapore 2017-2021 Noelia Tarazona Spain, Hospital Clinico Universitario de Valencia, Valencia 2019-2023 Melissa Ching Ching Teo Singapore, National Cancer Centre Singapore 2017-2021 Giampaolo Tortora Italy, Azienda Ospedaliera Universitaria Integrata, Verona 2017-2021 Nicola Valeri UK, Royal Marsden Hospital NHS Foundation Trust, London 2019-2023 Juan Valle UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Eric J.D. van Cutsem Belgium, University Hospital Gasthuisburg, Leuven 2017-2021 Hanneke van Laarhoven Netherlands, Medical Oncology Academic Medical Centre, Amsterdam 2017-2021 Marcel Verheij Netherlands, Netherlands Cancer Institute, Amsterdam 2017-2021 Benedikt Westphalen Germany, Ludwig Maximilians University – Grosshadern, Munich 2019-2023 Lucjan Wyrwicz Poland, The Maria Sklodowska-Curie Memorial Institute and Oncology Centre, Warsaw 2017-2021 Wei Peng Yong Singapore, National University of Singapore, Singapore 2017-2021 Takayuki Yoshino Japan, National Cancer Center Hospital East, Kashiwa 2018-2022

ESMO Faculty| Latest update 13 February 2019 10

Breast Cancer

Name Country/Institute/City Term of Office Faculty Coordinator Giuseppe Curigliano Italy, Istituto Europeo di Oncologia, Milan 2019-2020 Stefan Aebi Switzerland, Lucerne Cantonal Hospital, Lucerne 2017-2021 Frederic Amant Belgium, University Hospitals Leuven, Leuven 2017-2021 Fabrice André France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Monica Arnedos France, Institut Gustave Roussy, Villejuif 2017-2021 Evandro de Azambuja Belgium, Institute Jules Bordet, Brussels 2017-2021 Hatem A. Azim Jr. Belgium, Breast Data Centre, Breast Cancer Translational Research Laboratory, Brussels 2017-2021 Thomas Bachelot France, Centre Léon Bérard, Lyon 2017-2021 Carlos Barrios Brazil, PUCRS School of Medicine, Porto Alegre 2017-2021 Jonas Bergh Sweden, Karolinska Institutet and University Hospital, Stockholm 2017-2021 Gouri Bhattacharyya Fortis Hospital, Anandapur, Kolkata, West Bengal, India 2017-2021 Laura Biganzoli Italy, Nuovo Ospedale di Prato, Prato 2017-2021 José Bines Brazil, Instituto Nacional do Câncer, Rio de Janeiro 2017-2021 Hervé Bonnefoi France, Institute Bergonié, Bordeaux 2017-2021 Etienne Brain France, Institut Curie - Hôpital René Huguenin, Saint-Cloud 2017-2021 Fatima Cardoso Portugal, Champalimaud Cancer Center, Lisbon 2019-2023 Boon Chua Australia, Edmund Blacket Building, Prince of Wales Hospital, Randwick 2017-2021 Giovanni Codacci-Pisanelli Italy, University of Rome "la Sapienza", Rome 2017-2021 Pier Franco Conte Italy, Policlinico-Modena, Modena 2017-2021 Javier Cortes Spain, Hospital Universitario Ramón y Cajal, Madrid 2017-2021 Carmen Criscitiello Italy, European Institute of Oncology, Milan 2017-2021 Giuseppe Curigliano Italy, European Institute of Oncology, Milan 2017-2021 Leticia De Mattos-Arruda Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Suzette Delaloge France, Institut Gustave Roussy, Villejuif 2017-2021 Carsten Denkert Germany, Universitätsklinik Charité - Campus Virchow Klinikum, Berlin 2017-2021 Rebecca Dent Singapore, NCCS - National Cancer Centre Singapore, Sinagapore 2018-2022 Serena di Cosimo Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Angelo di Leo Italy, Hospital of Prato, Prato 2017-2021 Véronique Diéras France, Centre Eugene - Marquis, Rennes 2017-2021 Peter Dubsky Switzerland, Klinik St. Anna, Luzern 2017-2021 Nagi S. El Saghir Lebanon, Naef K. Basile Cancer Institute, Beirut 2017-2021 Alexandru Eniu Romania, The Oncology Institute „Prof. Dr. Ion Chiricuţă”, Cluj-Napoca 2017-2021

ESMO Faculty| Latest update 13 February 2019 11

Prudence Francis Australia, Peter MacCallum Cancer Center, Melbourne 2017-2021 Sandra Ximena Franco Colombia, Clinica del Country, Bogotà 2018-2022 Karen Gelmon Canada, British Columbia Cancer Agency, Vancouver 2017-2021 Alessandra Gennari Italy, Ente Ospedaliero Ospedali Galliera, Genoa 2017-2021 Luca Gianni Italy, IRCCS San Raffaele, Milan 2017-2021 Joseph Gligorov France, Hôpital Tenon (AP-HP), Paris 2017-2021 Anthony Gonçalves France, Institute Paoli-Calmettes, Marseille 2017-2021 Pamela Goodwin Canada, Samuel Lunenfeld Research Institute at Mount Sinai Hospital, Toronto 2017-2021 Nadia Harbeck Germany, Brustzentrum der Universität, München 2017-2021 Xichun Hu China, Fudan University Shanghai Cancer Center, Shangai 2019-2023 Michail Ignatiadis Belgium, Institute Jules Bordet, Brussels 2017-2021 Seock-Ah Im Korea, SNUH-Seoul National University Hospital, Seoul 2019-2023 Suthinee Ithimakin Thailand, Siriraj hospital, Bangkok 2019-2023 Hiroji Iwata Japan, Aichi Cancer Center Hospital, Nagoya 2019-2023 Wolfgang Janni Germany, University Hospital Ulm, Ulm 2017-2021 Guy Jerusalem Belgium, Centre Hospitalier Universitaire de Liège, Liège 2017-2021 Maria João Cardoso Portugal, Champalimaud Foundation, Lisbon 2017-2021 Heikki Joensuu Finland, Helsinki University Hospital, Helsinki 2017-2021 Stephen Johnston UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Peeter Karihtala Finland, Oulu University Hospital, Oulu 2017-2021 Vesa V. Kataja Finland, Kuopio University Hospital, Kuopio 2017-2021 Sung-Bae Kim Korea, Asan Medical Center, University of Ulsan College of Medicine, Seoul 2019-2023 Michael Knauer Switzerland, Cantonal Hospital St. Gallen, St. Gallen 2017-2021 Katsumasa Kuroi Japan, Tokyo Metropolitan health and Hospitals Corporation Ebara Hospital, Tokyo 2019-2023 Matteo Lambertini Belgium, Institute Jules Bordet, Brussels 2017-2021 Barbro Linderholm Sweden, Sahlgrenska Academy and University Hospital, Gothenburg 2017-2021 Caroline Lohrisch Canada, BC Cancer Agency, Vancouver 2017-2021 Sibylle Loibl Germany, German Breast Group Forschungs GmbH, Neu-Isenburg 2017-2021 Max Mano Brazil, University of São Paulo, São Paulo 2019-2023 Miguel Martin Jimenez Spain, Hospital General Universitario Gregorio Marañón, Madrid 2017-2021 David Miles UK, Mount Vernon Cancer Center, Northwood 2017-2021 René Munoz-Bermeo Ecuador, Hospital Oncologico Solca Quito, Quito 2019-2023 Shinji Ohno Japan, Japanese Foundation for Cancer Research, Tokyo 2017-2021 Ana Mafalda Oliveira Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Olivia Pagani Switzerland, IOSI - Ospedale Regionale Bellinzona e Valli, Bellinzona 2017-2021 Shani Paluch-Shimon Israel, Oncology Institute Sheba Medical Center, Ramat Gan 2017-2021 Fedro Peccatori Italy, European Institute of Oncology, Milan 2017-2021

Frédérique Penault-Llorca France, Centre Jean Perrin, Clermont-Ferrand 2017-2021

ESMO Faculty| Latest update 13 February 2019 12

Bernhard C. Pestalozzi Switzerland, University Hospital Zurich, Zurich 2017-2021 Martine Piccart Belgium, Institute Jules Bordet, Brussels 2017-2021 Jean-Yves Pierga France, Institut Curie, Paris 2017-2021 Xavier Pivot France, C.H.U Jean Minjoz, Besancon 2017-2021 Philip Poortmans Netherlands, Radboud University Medical Center, Nijmegen 2017-2021 Joana Ribeiro Portugal, Champalimaud Foundation, Lisbon 2017-2021 Cristina Saura Manich Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Elzbieta Senkus-Konefka Poland, Medical University of Gdansk, Gdansk 2017-2021 Peter Schmid UK, Barts Cancer Institute/Queen Mary University of London 2017-2021 Berta Sousa Portugal, Champalimaud Foundation Cancer Center, Lisbon 2017-2021 Jean-Philippe Spano France, Groupe Hospitalier Pitié-Salpêtrière, Paris 2017-2021 Benita Tan Singapore, SingHealth Duke-NUS Breast Centre, Singapore 2019-2023 Christoph Thomssen Germany, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale) 2017-2021 Masakazu Toi Japan, Kyoto University-Graduate school of medicine, Kyoto 2019-2023 Tibor Tot Sweden, Central Hospital Falun, Falun 2017-2021 Janice Tsang Hong Kong, Hong Kong Breast Oncology Group, Sheung Wan 2017-2021 Sunil Verma Canada, Tom Baker Cancer Centre, Calgary 2017-2021 Giuseppe Viale Italy, European Institute of Oncology, Milan 2017-2021 Anne Vincent-Salomon France, Institut Curie, Paris 2017-2021 Daniel Vorobiof South Africa, Sandton Oncology Centre, Sandton 2017-2021 Conny Vrieling Switzerland, Clinique des Grangettes, Geneva 2017-2021 Peter Vuylsteke Belgium, CHU UCL Namur - Site de Sainte-Elisabeth, Namur 2017-2021 Andrew Wardley UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Gustavo Werutsky Brazil, Latin American Cooperative Oncology Group (LACOG), Porto Alegre 2019-2023 Hans Wildiers Belgium, University Hospitals Leuven, Leuven 2017-2021 Binghe Xu China, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing 2017-2021 Yoon-Sim Yap Singapore, NCCS - National Cancer Centre Singapore 2019-2023 Sophia Zackrisson Sweden, Skåne's University Hospital, Malmö 2017-2021 Jin Zhang China, Tianjin Medical University Cancer Institute & Hospital, Tianjin 2019-2023

ESMO Faculty| Latest update 13 February 2019 13

Gynecologic Cancer

Name Country/Institute/City Term of Office Faculty Coordinator: Antonio González Martín Spain, MD Anderson Cancer Center, Madrid 2017-2020 Susana Banerjee UK, Royal Marsden Hospital NHS Foundation Trust, London 2017-2021 Carien L. Creutzberg Netherlands, Leiden University Medical Center, Leiden 2017-2021

Karina Dahl Steffensen Denmark, Department of Clinical Oncology, Vejle Hospital, Vejle 2017-2021 Maria Diz Brazil, ICESP - Instituto do Cancer do Estado de Sao Paulo 2019-2023 Rosalind M. Glasspool UK, Beatson West of Scotland Cancer Centre Gartnavel General Hospital, Glasgow 2017-2021 Charlie Gourley UK, University of Edinburgh, Edinburgh 2017-2021 Jonathan Ledermann UK, University College London, London 2017-2021 Domenica Lorusso Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Christian Marth Austria, University Hospital Innsbruck, Innsbruck 2017-2021 Mansoor Raza Mirza Denmark, Rigshospitalet - Copenhagen University Hospital, Copenhagen 2017-2021

Ana Oaknin Spain, Vall d´Hebron Institute of Oncology, Barcelona 2017-2021 Aikou Okamoto Japan, Jikei University School of Medicine, Tokyo 2019-2023 José Alejandro Pérez Fidalgo Spain, University Hospital of Valencia, Valencia 2017-2021 Sandro Pignata Italy, Istituto Nazionale dei Tumori di Napoli, Naples 2017-2021 Andrés Maria Poveda Spain, Instituto Valenciano de Oncologia, Valencia 2017-2021 Maria R. Raspollini Italy, University Hospital Careggi, Florence 2017-2021

Isabelle Ray-Coquard France, Centre Léon Bérard, Lyon 2017-2021 Cristiana Sessa Switzerland, Istituto Oncologico della Svizzera Italiana, Bellinzona 2017-2021 David Tan Singapore, NUS-National University of Singapore-National University Health System (NUHS) 2019-2023 Flora Chong Tze Malaysia, Hospital Likas, Kota Kinabalu 2019-2023

ESMO Faculty| Latest update 13 February 2019 14

Genitourinary Cancer

Name Country/Institute/City Term of Office Faculty Coordinator: Aristotelis Bamias Greece, Athens University, Athens 2017-2020

Laurence Albiges France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Ferran Algaba Spain, Fundacio Puigvert, Barcelona 2017-2021 Gerhardt Attard United Kingdom, The Institute of Cancer Research (Sutton Site), Sutton 2017-2021 Joaquim Bellmunt Spain, University Hospital del Mar, Barcelona 2017-2021 Axel Bex Netherlands, Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021 Carsten Bokemeyer Germany, University Medical Center Hamburg-Eppendorf, Hamburg 2017-2021 Petri Bono Finland, Helsinki University Hospital, Helsinki 2017-2021 Maurizio Brausi Italy, Ospedale Ramazzini di Carpi, Modena 2017-2021 Johann S. de Bono UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Maria de Santis UK, University of Warwick, Coventry 2017-2021 Ronald de Wit Netherlands, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam 2017-2021 David Dearnaley UK, Royal Marsden Hospital, Sutton 2017-2021 Tim Eisen UK, Addenbrooke’s University Hospital, Cambridge 2017-2021 Bernard Escudier France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Karim Fizazi France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Silke Gillessen Switzerland, Kantonsspital St. Gallen, St. Gallen 2017-2021 Alan Horwich UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Robert A. Huddart UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Ravindran Kanesvaran Singapore, National Cancer Centre Singapore, Singapore 2017-2021 Dimitrios Kardamakis Greece, University of Patras Medical School, Patras 2017-2021 Vesa V. Kataja Finland, Kuopio University Hospital, Kuopio 2017-2021 Christian Kollmannsberger Canada, British Columbia Cancer Agency, Vancouver 2017-2021 Jae-Lyun Lee Korea, Asan Medical Center, University of Ulsan College of Medicine, Seoul 2019-2023 Rodolfo Montironi Italy, Ospedali Riuniti Ancona 2017-2021 Nicolas Mottet France, CHU University hospital of St Etienne, St. Etienne 2018-2022 Andrea Necchi Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Sjoukje Oosting Netherlands, University Hospital Groningen (UMCG), Groningen 2019-2023 Stephane Oudard France, European Hospital Georges Pompidou, Paris 2017-2021 Mustafa Özgüroglu Turkey, Istanbul University - Cerrahpasa Faculty of Medicine, Istanbul 2017-2021 Camillo Porta Italy, Ospedale San Matteo, Pavia 2017-2021

Thomas Powles UK, St. Bartholomew’s Hospital, London 2017-2021

ESMO Faculty| Latest update 13 February 2019 15

Daniele Santini Italy, Università Campus Bio-Medico di Roma, Rome 2017-2021 Jack Schalken Netherlands, Radbound University Medical Centre Nijmegen, Nijmegen 2017-2021 Cora N. Sternberg Italy, Clinica Pio XI , Rome 2017-2021 Michiel Strijbos Belgium, A.Z. Klina, Brasschaat 2017-2021 Ian Tannock Canada, Princess Margaret Hospital, Toronto 2017-2021 Samra Turajlic UK, Royal Marsden Hospital NHS Foundation Trust, London 2018-2022 Hendrik Van Poppel Belgium, University Hospital Gasthuisburg, Leuven 2017-2021 Hans Von der Maase Denmark, Rigshospitalet-Copenhagen University Hospital, Copenhagen 2017-2021

ESMO Faculty| Latest update 13 February 2019 16

Sarcoma

Name Country/Institute/City Term of Office Faculty coordinator: Javier Martin Broto Spain, Hospital Universitario Son Espases, Palma de Mallorca 2017-2020 Jyoti Bajpai India, Tata Memorial Centre, Mumbai 2019-2023 Sebastian Bauer Germany, University Hospital Essen Westdeutsches Tumorzentrum, Essen 2017-2021 Stefan Bielack Germany, Klinikum Stuttgart - Olgahospital, Stuttgart 2017-2021 Jean-Yves Blay France, Centre Léon Bérard, Lyon 2017-2021

Sylvie Bonvalot France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021

Ioannis Boukovinas Greece, Theagenion Cancer Hospital, Thessaloniki 2017-2021 Thomas Brodowicz Austria, General Hospital - Medizinische Universität Wien, Vienna 2017-2021 Paolo G. Casali Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021

Enrique de Álava Spain, Virgen del Rocío University Hospital, Seville 2017-2021 Angelo P. Dei Tos Italy, Regional Hospital Treviso, Treviso 2017-2021 Mikael Eriksson Sweden, University Hospital Lund, Lund 2017-2021 Alexander Fedenko Russia, N. N. Blokhin Russian Cancer Research Center, Moscow 2017-2021 Andrea Ferrari Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Stefano Ferrari Italy, Istituto Ortopedico Rizzoli, Bologna 2017-2021 Anna Maria Frezza Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Hans Gelderblom Netherlands, Leiden University Medical Center, Leiden 2017-2021 Robert Grimer UK, Royal Orthopaedic Hospital, Birmingham 2017-2021 Alessandro Gronchi Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Peter Hohenberger Germany, Mannheim University Medical Center, Mannheim 2017-2021 Rolf Issels Germany, Ludwig Maximilians University - Grosshadern, Munich 2017-2021 Heikki Joensuu Finland, Helsinki University Central Hospital, Helsinki 2017-2021 Ian R. Judson UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Akira Kawai Japan, National Cancer Center Hospital, Tokio 2019-2023 Axel Le Cesne France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Ofer Merimsky Israel, Tel Aviv Sourasky Medical Center (Ichilov), Tel Aviv 2017-2021 Michael Montemurro Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Giannis Mountzios Greece, University of Athens - School of Medicine, Athens 2017-2021 Peter Reichardt Germany, Helios Klinikum Bad Saarow, Bad Saarow 2017-2021 Martin H. Robinson UK, University of Sheffield, Sheffield 2017-2021 Stefan Sleijfer Netherlands, Erasmus Medical Center, Rotterdam 2017-2021 Kirsten Sundby Hall Norway, Oslo University Hospital, Oslo 2017-2021

ESMO Faculty| Latest update 13 February 2019 17

Winette van der Graaf UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Jeremy Whelan UK, University College London Hospital UCLH NHS Foundation Trust, London 2017-2021

ESMO Faculty| Latest update 13 February 2019 18

Hematologic Malignancy

Name Country/Institute/City Term of Office Faculty Coordinator: Christian Buske Germany, University of Ulm, Ulm 2017-2020 Igor Aurer Croatia, School of Medicine University Zagreb, Zagreb 2017-2021 Johanna W. Baars Netherlands, Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021 Elias Campo Spain, Hospital Clínico y Provincial de Barcelona, Barcelona 2017-2021 George Canellos USA, Dana Farber Cancer Institute, Boston 2017-2021 Meletios A. Dimopoulos Greece, Alexandra Hospital, Athens 2017-2021 Martin Dreyling Germany, Medizinische Klinik und Poliklinik III Klinikum der Universität, Munich 2017-2021 Martin F. Fey Switzerland, University Hospital of Bern, Bern 2017-2021 Michele Ghielmini Switzerland, Istituto Oncologico Svizzera Italiana, Bellinzona 2017-2021 John Goodlad UK, Cancer Center Western General Hospital, Edinburgh 2017-2021

Michael Hallek Germany, University Hospital Cologne, Cologne 2017-2021 Eva K. Kimby Sweden, Karolinska University Hospital, Stockholm 2017-2021

Marco Ladetto Italy, Presidio Ospedaliero Civile SS. Antonio e Biagio, Alessandria 2017-2021 Steven Le Gouill France, CHU de Nates, Nantes 2017-2021 Armando Lopez-Guillermo Spain, Hospital Clinic y Provincial de Barcelona, Barcelona 2017-2021

Markus Manz Switzerland, University Hospital Zurich, Zurich 2017-2021 Uwe Platzbecker Germany, University Hospital Carl Gustav Carus, Dresden 2017-2021 John Radford UK, University of Manchester and The Christie NHS Foundation Trust, Manchester 2017-2021 Tadeusz Robak Poland, Koppernik Memory Hospital Lodz, Lodz 2017-2021 Jesus San-Miguel Spain, University Hospital of Salamanca, Salamanca 2017-2021 Umberto Vitolo Italy, Azienda Ospedaliera Universitaria S.Giovanni Battista - Molinette, Torino 2017-2021 Jan Walewski Poland, MSC Memorial Cancer Center and Institute of Oncology, Warsaw 2017-2021 Emanuele Zucca Switzerland, Istituto Oncologico Svizzera Italiana, Bellinzona 2017-2021

ESMO Faculty| Latest update 13 February 2019 19

Principles of Clinical Trials and Systemic Therapy

Name Country/Institute/City Term of Office Faculty Coordinator: Ahmad Awada Belgium, Institute Jules Bordet, Brussels 2017-2020 Steiner Aamdal Norway, University Hospital Rikshospitalet, Oslo 2017-2021 Alex A. Adjei USA, Mayo Clinic, Rochester 2017-2021 Guillem Argiles Spain, Vall d'Hebron University Hospital, Barcelona 2017-2021 Dirk Arnold Germany, Clinic for Tumour Biology, Freiburg 2017-2021 Udai Banerji UK, Royal Marsden Hospital Institute of Cancer Research, Sutton 2017-2021 Yazid Belkacémi France, Henri Mondor University Hospital, Paris 2017-2021 Jean-Yves Blay France, Centre Leon Berard, Lyon 2017-2021 Emiliano Calvo Spain, Madrid Norte Sanchinarro University Hospital, Madrid 2017-2021 Fatima Cardoso Portugal, Champalimaud Cancer Center, Lisbon 2017-2021 Thomas Cerny Switzerland, Kantonsspital St. Gallen, St. Gallen 2017-2021 Sarah Coupland UK, University of Liverpool, Liverpool 2017-2021 Urania Dafni Greece, University of Athens, Athens 2017-2021 Gilberto De Castro Jr. Brazil, ICESP - Instituto do Cancer do Estado de Sao Paulo 2019-2023 Christian Dittrich Austria, Keiser Franz Josef Hospital, Vienna 2017-2021 Vincent Donckier Belgium, Institute Jules Bordet, Brussels 2017-2021 Paul Haluska USA, Mayo Clinic, Rochester 2017-2021 Nadia Harbeck Germany, Brustzentrum der Universität München, Munich 2017-2021 Peter Hohenberger Germany, Mannheim University Medical Center, Mannheim 2017-2021 Filip Janku USA, MD Anderson Cancer Center, Houston 2017-2021 Ulrich Keilholz Germany, Charité Campus Benjamin Franklin, Berlin 2017-2021 Denis Lacombe Belgium, European Organization for Research, Brussels 2017-2021

Anita Margulies Switerland, EONS, Zurich 2017-2021 Paul Morten Mau-Sorensen Denmark, Rigshospitalet, Copenhagen 2017-2021

Mahesh Parmar UK, Medical Research Council - Clinical Trials Unit, London 2017-2021 Patrick Pauwels Belgium, Antwerp University Hospital (UZA), Edegem 2017-2021 Nicolas Penel France, Centre Oscar Lambret, Lille 2017-2021 Eric Raymond Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Christoph Roecken Germany, UK-SH, Campus Kiel, Kiel 2017-2021 Piotr Rutkowski Poland, MSC Memorial Cancer Center and Institute of Oncology, Warsaw 2017-2021 Jan H.M. Schellens Netherlands, The Netherlands Cancer Institute, Amsterdam 2017-2021 Gilberto Schwartsmann Brazil, Hospital de Clinicas de Porto Alegre, Porto Alegre 2017-2021

ESMO Faculty| Latest update 13 February 2019 20

Stefan Sleijfer Netherlands, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam 2017-2021 Alberto Sobrero Italy, Istituto Nazionale per le Ricerca sul Cancro, Genoa 2017-2021 Roger Stupp Switzerland, Centre Hospitalier Universitaire Vaudois - CHUV, Lausanne 2017-2021 Joseph Tabernero Spain, Vall d`Hebron Institute of Oncology, Barcelona 2017-2021 Ian Tannock Canada, Princess Margaret Hospital, Toronto 2017-2021 Margaret Tempero USA, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco 2017-2021 Marcel Verheij Netherlands, Antoni van Leeuwenhoek Cancer Institute, Amsterdam 2017-2021

ESMO Faculty| Latest update 13 February 2019 21

Cancer Research

Name Country/Institute/City Term of Office Faculty Coordinator: Carlos Caldas UK, Addenbrooke's Hospital University of Cambridge Hospitals, Cambridge 2019-2020 Alberto Bardelli Italy, IRCCS Istituto di Candiolo, Torino 2017-2021 Caroline Dive UK, Cancer Research UK Manchester Institute, Manchester 2017-2021 Reinhard Dummer Switzerland, University Hospital Zürich, Zürich 2017-2021 Keith Flaherty USA, Massachusetts General Hospital, Boston 2017-2021 Carlos Gomez-Roca France, Institut Universitaire du Cancer -Toulouse- Oncopole, Toulouse 2019-2023 Richard Marais UK, Cancer Research UK Manchester Institute, The University of Manchester 2019-2023

Marco A. Pierotti Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Eli Pikarsky Israel, The Hebrew University of Jerusalem-Hadassah School of Medicine, Jerusalem 2017-2021 Jorge Reis-Filho USA, Memorial Sloan-Kettering Can, New York 2017-2021 Caroline Robert France, Institut Gustave Roussy, Villejuif 2017-2021 Jordi Rodon Spain, Vall d`Hebron Institute of Oncology, Barcelona 2017-2021 Joan Seoane Spain, Vall d’Hebron Institute of Oncology, Barcelona 2017-2021

Charles Swanton UK, University College London Hospital, London 2017-2021 Giampaolo Tortora Italy, Azienda Ospedaliera Universitaria Integrata Verona, Verona 2017-2021 Joannes H. Van Krieken Netherlands, Radboud UMC, Nijmegen 2017-2021 Emmy Verschuren Finland, University of Helsinki, Helsinki 2017-2021

Christof von Kalle Germany, National Center for Tumor Diseases Heidelberg, Heidelberg 2017-2021

ESMO Faculty| Latest update 13 February 2019 22

Cancer Prevention

Name Country/Institute/City Term of Office Faculty Coordinator: Nadir Arber Israel, Tel Aviv Sourasky Medical Center, Tel Aviv 2019-2020

Philippe Autier France, University of Strathclyde Institute of Global Public Health, Lyon 2017-2021 Peter Boyle France, International Prevention Research Institute, Ecully 2019-2023 Jack Cuzick UK, Queen Mary University of London, London 2017-2021 Alexandru Eniu Romania, Ion Chiricuta Oncology Institute, Cluj Napoca 2017-2021 Franz Porzsolt Germany, University of Ulm, Ulm 2017-2021 Dirk Schrijvers Belgium, University Hospital, Antwerp-Middelheim, Antwerp 2017-2021 Richard Sullivan UK, Institute of Cancer Policy, London 2017-2021 Thomas Szucs Switzerland, Institute of Pharmaceutical Medicine, University of Basel, Basel 2017-2021 Miri Ziv Israel, Israel Cancer Association, Givatayim 2017-2021

ESMO Faculty| Latest update 13 February 2019 23

Supportive and Palliative Care

Name Country/Institute/City Term of Office Faculty Coordinator: Karin Jordan Germany, Martin-Luther-University of Halle, Halle 2017-2020 Matti S. Aapro Switzerland, Clinique de Genolier, Genolier 2017-2021

Jean-Jacques Body Belgium, CHU Brugmann, Brussels 2017-2021 Carsten Bokemeyer Germany, University Clinic Hamburg-Eppendorf, Hamburg 2017-2021 Snezana Bosnjak Serbia, Institute of Oncology and Radiology of Serbia, Belgrade 2017-2021 Ricardo Caponero Brazil, Clínica de Oncologia Médica, São Paulo 2017-2021

Raphael Catane Israel, Sheba Medical Center, Tel-Hashomer 2017-2021 Martin Chasen Canada, Elizabeth Bruyere Hospital, Ottawa 2017-2021 Nathan I. Cherny Israel, Shaare Zedek Medical Center, Jerusalem 2017-2021 Robert Coleman UK, University of Sheffield, Sheffield 2017-2021 Jeffrey Crawford USA, Duke University Medical Center, Durham 2017-2021 Mario A. Dicato Luxembourg, Centre Hospitalier de Luxembourg, Luxembourg 2017-2021 Marie Fallon UK, University of Edinburgh, Edinburgh 2017-2021 Petra Feyer Germany, Krankenhaus Neuköllm, Berlin 2017-2021

Azza Adel Hassan Egypt, Medical Research Institute, Alexandria University, Alexandria 2017-2021 Jorn Herrstedt Denmark, Odense University Hospital, Odense 2017-2021 David Hui USA, MD Anderson Cancer Center, Houston 2017-2021 Yeur-Hur Lai Taiwan, National Taiwan University, Taipei 2017-2021 Lorenz Jost Switzerland, Kantonsspital, Bruderholz 2017-2021 Stein Kaasa Norway, St. Olav's University Hospital, Trondheim 2017-2021 Dorothy Keefe Australia, Royal Adelaide Hospital RAH Cancer Centre, Adelaide 2017-2021 Alex Molasiotis Hong Kong, The Hong Kong Polytechnic University, Hong Kong 2019-2023 Ian Olver Australia, Sansom Institute for Health Research - University of South Australia, Adelaide 2017-2021 Bernardo L. Rapoport South Africa, The Medical Oncology Centre of Rosebank, Johannesburg 2017-2021 Carla Ripamonti Italy, Fondazione IRCCS -Istituto Nazionale dei Tumori, Milan 2017-2021 Fausto Roila Italy, Santa Maria Hospital, Terni 2017-2021 Christina Ruhlmann Denmark, Odense University Hospital, Odense 2017-2021 Tiina Saarto Finland, Helsinki University Central Hospital, Helsinki 2017-2021 Mitsue Saito Japan, Juntendo University Hospital, Tokyo 2019-2023 Dirk Schrijvers Belgium, University Hospital, Antwerp-Middelheim, Antwerp 2017-2021 Florian Scotté France, Hopital European George Pompidou, Paris 2017-2021 Anton Snegovoy Russian Federation, N.N. Blokhin Russian Cancer Research Center, Moscow 2017-2021

ESMO Faculty| Latest update 13 February 2019 24

Florian Strasser Switzerland, Cantonal Hospital, St. Gallen, St. Gallen 2017-2021 Kazuo Tamura Japan, Fukuoka University, Fukuoka 2017-2021 Simon J.P. Van Belle Belgium, Ghent University Hospital, Gent 2017-2021 Declan Walsh Ireland, Trinity College School of Medicine & Medical Sciences, University College Dublin 2017-2021 Jayne Elizabeth Wood UK, The Royal Marsden NHS Foundation Trust, London 2017-2021 Annie Young UK, University of Warwick, Coventry 2017-2021 Heinz Zwierzina Austria, Universtiy Hospital Innsbruck, Innsbruck 2017-2021

ESMO Faculty| Latest update 13 February 2019 25

Cancer Genetics

Name Country/Institute/City Term of Office Faculty Coordinator: Judith Balmaña Spain, Vall d'Hebron University Hospital, Barcelona 2017-2020 Patrick Benusiglio France, Hospital Group Pitié-Salpêtrière - Charles Foix, Paris 2017-2021 Gabriel Capella Spain, L'Hospitalet de Llobregat, Barcelona 2017-2021 Raphael Catane Israel, Sheba Medical Center, Ramat Gan 2017-2021 Diana Eccles UK, University Hospital Southampton, Southampton 2017-2021 Maurizio Genuardi Italy, Università Cattolica del Sacro Cuore, Rome 2019-2023 Nicoline Hoogerbrugge Netherlands, Radboud University Medical Center, Nijmegen 2017-2021 Evgeny Imyanitov Russia, Petrov Research Institute of Oncology, St. Petersburg 2017-2021 Kyriacos Kyriacou Cyprus, The Cyprus Institute of Neurology and Genetics, Nicosia 2017-2021 Pierre Laurent-Puig France, European Hospital George Pompidou, Paris 2017-2021 Marjolijn Ligtenberg Netherlands, Radboud University Medical Center, Nijmegen 2019-2023 Niklas Loman Sweden, Skåne's University Hospital, Malmö 2017-2021 James Mackay UK, University College London, London 2017-2021 Lina Nuñez Argentina, Instituto Nacional del Cancer, Buenos Aires 2019-2023 Carla Oliveira Portugal, Instituto de Patologia e Imunologia Molecular da Universidade do Porto 2017-2021 Augusto Pedrazzini Switzerland, Oncologia Lago Maggiore, Locarno 2017-2021 Violeta Serra Spain, Vall d’Hebron University Hospital, Barcelona 2017-2021 Rolf Sijmons Netherlands, University College of Groningen, Groningen 2019-2023 Giorgio Stanta Italy, University of Trieste/Cattinara Hospital, Trieste 2017-2021 Sabine Tejpar Belgium, University Hospital Gasthuisberg, Leuven 2017-2021

ESMO Faculty| Latest update 13 February 2019 26

CNS Tumours

Name Country/Institute/City Term of Office Faculty Coordinator: Emilie Le Rhun France, University Hospital, Lille 2017-2020 Brigitta Baumert Netherlands, Maastricht University Medical Center, (MUMC), Maastricht 2017-2021 Alba A. Brandes Italy, Ospedale Bellaria, Bologna 2017-2021 Mario Campone France, Institut de Cancérologie de L’Ouest Renö Gauducheau, Nantes 2017-2021 Jean-Sebastien Frenel France, Institut de Cancerologie de l’Ouest, Saint-Herblain 2017-2021 Monika Hegi Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Roger Henriksson Sweden, Karolinska University Hospital-Solna, Stockholm 2017-2021 Khe Hoang-Xuan France, Centre Hospitalier Universitaire Pitié-Salpêtrière, Paris 2017-2021 Christine Marosi Austria, Medical University of Vienna, Vienna 2017-2021 Simone Niclou Luxembourg, Centre de Recherche Public de la Santé, Luxembourg 2017-2021 Jeannette Parkes South Africa, University of Cape Town, Cape Town 2017-2021 Matthias Preusser Austria, General Hospital (AKH), Vienna 2017-2021 Michele Reni Italy, IRCCS San. Raffaele, Milan 2017-2021 Jordi Rodon Spain, Vall d’Hebron University Hospital, Barcelona 2017-2021 Roger Stupp Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2021 Martin J.B. Taphoorn Netherlands, Medical Center Haaglanden, The Hague 2017-2021 Joerg-Christian Tonn Germany, Ludwig Maximilians University - Grosshadern, Munich 2017-2021 Martin Van den Bent Netherlands, Erasmuc MC, Rotterdam 2017-2021 Michael Weller Switzerland, University Hospital Zurich, Zurich 2017-2021 Pieter Wesseling Netherlands, Radboud University Nijmegen Medical Center, Amsterdam 2017-2021 Manfred Westphal Germany, University Hospital Hamburg Eppendorf, Hamburg 2017-2021 Wolfgang Wick Germany, University of Heidelberg, Heidelberg 2017-2021

ESMO Faculty| Latest update 13 February 2019 27

Neuroendocrine, Endocrine Neoplasms and CUP

Name Country/Institute/City Term of Office Faculty Coordinator: Nicola Fazio Italy, European Institute of Oncology, Milan 2016-2019

Valentina Ambrosini Italy, University of Bologna, Bologna 2017-2021 Richard Baum Germany, Zentralklinik Bad Berka, Bad Berka 2017-2021 Alfredo Berruti Italy, University of Turin, Turin 2017-2021 Lisa Bodei USA, Memorial Sloan Kettering Cancer Center, New York 2017-2021 Gedske Daugaard Denmark, Department of Oncology - University of Copenhagen, Copenhagen 2017-2021 Henning Dralle Germany, Martin-Luther-University Hospital, University of Halle, Halle 2017-2021

Michel Ducreux France, Institut Gustave Roussy, Villejuif 2017-2021 Rossella Elisei Italy, University of Pisa, Pisa 2017-2021 Massimo Falconi Italy, San Raffaele Hospital, Milan 2017-2021 Diego Ferone Italy, University of Genoa, Genoa 2017-2021 Karim Fizazi France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Andrea Frilling UK, Imperial College London, London 2017-2021 Rocio Garcia-Carbonero Spain, Hospital Universitario Doce de Octubre, Madrid 2017-2021 Hans Gelderblom Netherlands, Leiden University Medical Center, Leiden 2017-2021 Enrique Grande Pulido Spain, Hospital Universitario Ramón y Cajal, Madrid 2017-2021 Frank A. Greco USA, Sarah Cannon Cancer Center and Research, Nashville 2017-2021 Simona Grozinski Glasberg Israel, Hadassah Medical Center, Jerusalem 2017-2021 Gregorios Kaltsas Greece, National University of Athens, Athens 2017-2021 Yersu Kapran Turkey, Vehbi Koc American Hospital, Istanbul 2017-2021

Angela Lamarca UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Riccardo Marconcini Italy, Azienda Ospedaliera-Universitaria Pisana – Ospedale S. Chiara Pisa, Pisa 2017-2021 Dermot O'Toole Ireland, St James's Hospital, Dublin 2017-2021 Kjell Oeberg Sweden, University Hospital Uppsala, Uppsala 2017-2021 Marianne Pavel Germany, Charité Universitätsmedizin Berlin, Berlin 2017-2021 Nicholas Pavlidis Greece, University of Ioannina, Ioannina 2017-2021 George Pentheroudakis Greece, University Hospital of Ioannina, Ioannina 2017-2021 Marie Pierre Vullierme France, Beaujon Hospital, Clichy 2017-2021 Guido Rindi Italy, Fondazione Policlinico Universitario A. Gemelli, Rome 2017-2021 Martin Schlumberger France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Eva Segelov Australia, Monash Health and Monash University, Melbourne 2017-2021 Halfdan Sorbye Norway, Haukeland University Hospital, Bergen 2017-2021

ESMO Faculty| Latest update 13 February 2019 28

Eva Tiensuu Janson Sweden, Uppsala University, Uppsala 2017-2021 Juan Valle UK, The Christie NHS Foundation Trust, Manchester 2017-2021 Agnes Van de Wouw Netherlands, VieCuri MC, Venlo 2017-2021 Chris Verslype Belgium, University Hospitals Leuven, Leuven 2017-2021 James Yao USA, MD Anderson Cancer Center, Houston 2017-2021

ESMO Faculty| Latest update 13 February 2019 29

Melanoma

Name Country/Institute/City Term of Office Faculty coordinator: Olivier Michielin Switzerland, Centre Hospitalier Universitaire Vaudois, Lausanne 2017-2020 Paolo Ascierto Italy, Istituto Nazionale dei Tumori - Fondazione Pascale, Naples 2017-2021 Dimitrios Bafaloukos Greece, Technological University of Athens, Piraeus 2017-2021 Juergen Becker Austria, Medical University of Graz, Graz 2017-2021 Christian Blank Netherlands, The Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam 2017-2021

Thomas Brenn UK, Cancer Center Western General Hospital, Edinburgh 2017-2021 Reinhard Dummer Switzerland, University Hospital Zurich, Zurich 2017-2021 Alexander M.M. Eggermont France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021 Jean Jacques Grob France, Hospital St. Marguerite, Marseille 2017-2021 Axel Hauschild Germany, University Hospital UKSH, Kiel 2017-2021 Christoph Höller Austria, Vienna General Hospital, Vienna 2017-2021 Ulrich Keilholz Germany, Charité Campus Benjamin Franklin, Berlin 2017-2021 Celeste Lebbé France, Hospital S. Louis, Paris 2017-2021

Josep Malvehy Spain, Hospital Clinic y Provincial de Barcelona, Barcelona 2017-2021 Salvador Martin Algarra Spain, Clinica Universitaria de Navarra, Pamplona 2017-2021 Caroline Robert France, Institut Gustave Roussy, Villejuif 2017-2021 Teresa Troiani Italy, AOU Policlinico Federico II, Naples 2017-2021

John Wagstaff UK, South West Wales Cancer Institute, Singleton Hospital, Swansea 2017-2021

ESMO Faculty| Latest update 13 February 2019 30

Tumour Immunology and Immunotherapy

Name Country/Institute/City Term of Office Faculty coordinator:

John Haanen Netherlands, Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam 2016-2019

Victoria Atkinson Australia, Princess Alexandra Hospital, Woolloongabba 2019-2023 Mario Colombo Italy, Fondazione IRCCS - Istituto Nazionale dei Tumori, Milan 2017-2021 Alessandra Curioni Switzerland, University Hospital Zurich, Zurich 2017-2021 Marco Donia Denmark, Herlev Hospital 2019-2023 Andrew Furness UK, University College London Cancer Institute, London 2019-2023 Ulrich Keilholz Germany, Campus Charité Universitätsklinikum, Berlin 2017-2021 Alexander Knuth Qatar, National Center for Cancer Care & Research NCCCR, Doha 2017-2021

Athanasios Kotsakis Greece, University Hospital of Heraklion, Heraklion 2017-2021 Evan J. Lipson USA, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore 2018-2022 Alexander Marx Germany, Heidelberg University Medical Center Mannheim, Mannheim 2017-2021 Alexander Menzies Australia, Melanoma Institute Australia, University of Sydney, North Sydney 2019-2023 Rodrigo Munhoz Brazil, Hospital Sírio LÍbanês, Sao Paulo 2019-2023 Kenneth O'Byrne Australia, Princess Alexandra Hospital, Woolloongabba 2019-2023 Kjell Oeberg Sweden, University Hospital, Uppsala 2017-2021

Rienk Offringa Germany, German Cancer Research Center, Heidelberg 2017-2021 Naiyer Rizvi USA, Columbia University Hospital, New York 2017-2021 Emanuela Romano France, Institut Curie, Paris 2019-2023 Rolf A. Stahel Switzerland, University Hospital Zurich, Zurich 2017-2021 Michele Teng Australia, QIMR Berghofer Medical Research Institute, Brisbane 2019-2023 Han Chong Toh Singapore, National Cancer Centre Singapore 2019-2023 Laurence Zitvogel France, Institut de Cancérologie Gustave Roussy, Villejuif 2017-2021